Quest Diagnostics Incorporated
DGX
$178.03
-$0.81-0.45%
NYSE
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 1.99% | 4.11% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 1.99% | 4.11% | |||
| Cost of Revenue | 2.64% | 1.91% | |||
| Gross Profit | 0.74% | 8.63% | |||
| SG&A Expenses | 2.29% | 3.67% | |||
| Depreciation & Amortization | 0.00% | 0.00% | |||
| Other Operating Expenses | -50.00% | 300.00% | |||
| Total Operating Expenses | 2.48% | 2.36% | |||
| Operating Income | -0.71% | 14.95% | |||
| Income Before Tax | -14.50% | 33.67% | |||
| Income Tax Expenses | -20.62% | 64.41% | |||
| Earnings from Continuing Operations | -12.50% | 25.96% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 0.00% | 6.67% | |||
| Net Income | -13.12% | 28.18% | |||
| EBIT | -0.71% | 14.95% | |||
| EBITDA | -0.71% | 11.42% | |||
| EPS Basic | -13.52% | 27.16% | |||
| Normalized Basic EPS | -2.25% | 20.70% | |||
| EPS Diluted | -12.55% | 27.32% | |||
| Normalized Diluted EPS | -2.25% | 21.78% | |||
| Average Basic Shares Outstanding | 0.00% | 0.90% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | 0.00% | 0.00% | |||
| Payout Ratio | 0.14% | -0.16% | |||